Studies thus far are limited not only by the lack of standardized diagnosis and treatment methods, but also by the lack of safer and well-standardised IgE-reactive recombinant allergens and their hypoallergenic variants, as well as by the lack of longitudinal population-based studies with a holistic approach to egg allergies. Here, IGHE is linked to allergic disease.